ELVN
Price
$16.76
Change
-$0.17 (-1.00%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
830.74M
77 days until earnings call
SER
Price
$5.93
Change
+$0.52 (+9.61%)
Updated
May 22, 03:50 PM (EDT)
Capitalization
53.92M
Interact to see
Advertisement

ELVN vs SER

Header iconELVN vs SER Comparison
Open Charts ELVN vs SERBanner chart's image
Enliven Therapeutics
Price$16.76
Change-$0.17 (-1.00%)
Volume$1.7K
Capitalization830.74M
Serina Therapeutics
Price$5.93
Change+$0.52 (+9.61%)
Volume$250
Capitalization53.92M
ELVN vs SER Comparison Chart
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. SER commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Hold and SER is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (ELVN: $16.93 vs. SER: $5.41)
Brand notoriety: ELVN and SER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 54% vs. SER: 229%
Market capitalization -- ELVN: $830.74M vs. SER: $53.92M
ELVN [@Biotechnology] is valued at $830.74M. SER’s [@Biotechnology] market capitalization is $53.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whileSER’s FA Score has 0 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • SER’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than SER.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 4 TA indicator(s) are bullish.

  • ELVN’s TA Score: 4 bullish, 5 bearish.

Price Growth

ELVN (@Biotechnology) experienced а -14.88% price change this week, while SER (@Biotechnology) price change was -3.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

ELVN is expected to report earnings on Aug 07, 2025.

SER is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($831M) has a higher market cap than SER($53.9M). SER YTD gains are higher at: 7.984 vs. ELVN (-24.756). ELVN has more cash in the bank: 313M vs. SER (3.19M). ELVN has less debt than SER: ELVN (0) vs SER (11.5M).
ELVNSERELVN / SER
Capitalization831M53.9M1,542%
EBITDA-104.24MN/A-
Gain YTD-24.7567.984-310%
P/E RatioN/A1.60-
Revenue0N/A-
Total Cash313M3.19M9,827%
Total Debt011.5M-
FUNDAMENTALS RATINGS
SER: Fundamental Ratings
SER
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELVN
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCSIX39.07N/A
N/A
Sterling Capital SmCp Val R6
MSEPX21.86N/A
N/A
Morgan Stanley Inst Emerging Mkts C
BIERX25.22N/A
N/A
Brandes International Equity R6
BPGSX13.17N/A
N/A
Boston Partners Global Sustainablty Ins
LAFPX19.18N/A
N/A
Lord Abbett Affiliated P

SER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SER has been closely correlated with LIANY. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if SER jumps, then LIANY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SER
1D Price
Change %
SER100%
-5.26%
LIANY - SER
69%
Closely correlated
N/A
GERN - SER
65%
Loosely correlated
-3.60%
XTLB - SER
59%
Loosely correlated
-4.55%
ELVN - SER
37%
Loosely correlated
-2.59%
TOVX - SER
34%
Loosely correlated
+5.46%
More